Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
香烟烟雾衍生的亲电醛与气道炎症
基本信息
- 批准号:8628126
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-07 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcroleinAcuteAcute Lung InjuryAddressAdjuvantAdverse effectsAffectAldehydesAlkylationAllergicAllergic inflammationAlveolar MacrophagesAnti-Inflammatory AgentsAnti-inflammatoryAntigen-Presenting CellsAntigensAntioxidantsAsthmaAttenuatedBacterial InfectionsBeliefBreathingCell MaturationCellsChildhoodChronicChronic Obstructive Airway DiseaseChronic lung diseaseCystathionineCysteine Metabolism PathwayDendritic CellsDevelopmentDiseaseDrug Metabolic DetoxicationEnvironmental ExposureEnvironmental PollutantsEnzymesEosinophiliaEpithelialEpithelial CellsExposure toExtrinsic asthmaGenetic PolymorphismGlutathione S-TransferaseGoalsHealthHomoHost DefenseHydrogen SulfideImmune responseImmune systemImmunosuppressionImmunosuppressive AgentsIn VitroInfectionInflammationInflammatoryInjuryKnockout MiceLipopolysaccharidesLungLung diseasesMAPK9 geneMacrophage ActivationMalignant neoplasm of lungMediatingMediator of activation proteinMetabolicMetabolismMetaplasiaModelingModificationMucous body substanceMusOvalbuminOxidation-ReductionOxidative StressPathway interactionsPost-Translational Protein ProcessingPredispositionProductionPropertyProteinsProteomicsReactive Oxygen SpeciesRegulationRespiratory Tract InfectionsSeveritiesSignal TransductionSmall Interfering RNASmokingSulfhydryl CompoundsSystemTranscription Factor AP-1Transgenic OrganismsUnited States National Institutes of HealthVirus Diseasesairway inflammationallergic airway diseaseallergic airway inflammationbasecigarette smoke-inducedcigarette smokingcigarette smokingcytokinedesigneosinophilglobal healthin vivoinsightinterestmacrophagemouse modelneutrophilpreventprotective effectrespiratoryresponsethioredoxin reductasetumor
项目摘要
DESCRIPTION (provided by applicant): Cigarette smoking remains a major global health burden and is strongly associated with increased childhood respiratory infections and development of chronic lung diseases such as COPD, asthma and lung cancer. The adverse health effects of cigarette smoke (CS) are largely related to its immuno-suppressive properties leading to impaired innate immune responses, host defense, and tumor surveillance. Although it is commonly thought that these effects are due to CS-derived reactive oxygen species (ROS), largely based on observations of protective effects of thiol-based antioxidants, the main thiol-reactive agents within CS are acrolein (2,3- propenal) and other related unsaturated aldehydes. Our recent studies in mice have demonstrated immunosuppressive effects of acrolein on alveolar macrophages that mimic those of CS. Acute mechanisms associated with direct and transient alkylation of redox-sensitive protein targets appear to be critical in this respect, diretly affecting activation of NF-?B or AP-1 and altering cellular redox regulation. However, the specific functional consequences of these protein alkylations are not known. Acrolein exposure also mimics some of the variable effects of cigarette smoking on asthma development and severity, by promoting allergic sensitization but also by suppressing allergic inflammation. These effects of acrolein were associated with increased epithelial injury and are likely mediated by altered epithelial barrier integrity and interaction with dendritic cells, the main antigen-presentng cell in the lung, although the mechanisms by which acrolein impacts on epithelial integrity and production of mediators that regulate dendritic cell maturation are not known. The main goal of the present proposal is to elucidate the mechanisms by which acrolein alters innate macrophage and epithelial immune responses as well as allergic inflammation, and to identify the importance of direct alkylation of critical enzyme systems. We plan to determine the importance of direct protein modifications in acrolein-induced suppression of innate immune responses (Aim 1), using newly developed proteomic approaches and analysis of the functional importance of these modifications in target proteins, and explore the consequences of acrolein exposure on allergic inflammation and sensitization (Aim 2), focusing on alterations in epithelial barrier function and mediator production in association with direct alkylation or relevant target proteins. Also, based on recent studies indicating that acrolein is detoxified by glutathione S-transferase P1 (GSTP1) and by hydrogen sulfide (H2S), a newly recognized endogenous mediator produced by (homo)cysteine metabolism by cystathionine ¿-synthase (CBS), we will explore the importance of GSTP1 and CBS/H2S in modulating acrolein-induced alterations in immune responses (Aim 3). Collectively, these studies will not only offer important insights into the potential contribution of acrolein to CS-related disease, but may also be relevant to understanding the actions of other relevant endogenous or environmental electrophiles.
描述(由申请人提供):吸烟仍然是全球主要的健康负担,并且与儿童呼吸道感染的增加以及慢性肺病(如慢性阻塞性肺病、哮喘和肺癌)的发展密切相关。香烟烟雾(CS)对健康的不利影响很大程度上与其免疫抑制特性有关,导致先天免疫反应、宿主防御和肿瘤监测受损。尽管人们普遍认为这些作用是由 CS 衍生的活性氧 (ROS) 引起的,但主要基于对硫醇基抗氧化剂的保护作用的观察,CS 中的主要硫醇反应剂是丙烯醛 (2,3-丙烯醛) 和其他相关的不饱和醛。我们最近对小鼠的研究表明,丙烯醛对肺泡巨噬细胞具有类似于 CS 的免疫抑制作用。与氧化还原敏感蛋白靶标的直接和瞬时烷基化相关的急性机制似乎在这方面至关重要,直接影响 NF-κB 或 AP-1 的激活并改变细胞氧化还原调节。然而,这些蛋白质烷基化的具体功能后果尚不清楚。丙烯醛暴露还模仿了吸烟对哮喘发展和严重程度的一些可变影响,通过促进过敏性敏化和抑制过敏性炎症。丙烯醛的这些作用与上皮损伤增加有关,并且可能是通过改变上皮屏障完整性以及与树突状细胞(肺中主要抗原呈递细胞)的相互作用介导的,尽管丙烯醛影响上皮完整性和调节树突状细胞成熟的介质产生的机制尚不清楚。本提案的主要目标是阐明丙烯醛改变先天巨噬细胞和上皮免疫反应以及过敏性炎症的机制,并确定关键酶系统直接烷基化的重要性。我们计划使用新开发的蛋白质组学方法和分析目标蛋白中这些修饰的功能重要性,确定直接蛋白质修饰在丙烯醛诱导的先天免疫反应抑制中的重要性(目标 1),并探索丙烯醛暴露对过敏性炎症和致敏的影响(目标 2),重点关注与直接烷基化或相关的上皮屏障功能和介质产生的改变。 相关靶蛋白。此外,最近的研究表明丙烯醛可以通过谷胱甘肽 S-转移酶 P1 (GSTP1) 和硫化氢 (H2S) 解毒,硫化氢 (H2S) 是一种新认识的内源性介体,由胱硫醚 ¿-合酶 (CBS) 的(同)半胱氨酸代谢产生,我们将探讨 GSTP1 和 CBS/H2S 在调节中的重要性。 丙烯醛诱导的免疫反应改变(目标 3)。总的来说,这些研究不仅将为丙烯醛对 CS 相关疾病的潜在贡献提供重要见解,而且还可能有助于了解其他相关内源性或环境亲电子试剂的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALBERT VAN DER VLIET其他文献
ALBERT VAN DER VLIET的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALBERT VAN DER VLIET', 18)}}的其他基金
DUOX1 in fibroblast-macrophage cross-talk in pulmonary fibrosis
肺纤维化中成纤维细胞-巨噬细胞串扰中的 DUOX1
- 批准号:
10544804 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
DUOX1 in fibroblast-macrophage cross-talk in pulmonary fibrosis
肺纤维化中成纤维细胞-巨噬细胞串扰中的 DUOX1
- 批准号:
10353646 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
香烟烟雾衍生的亲电醛与气道炎症
- 批准号:
8815177 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
香烟烟雾衍生的亲电醛与气道炎症
- 批准号:
8484841 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation
香烟烟雾衍生的亲电醛与气道炎症
- 批准号:
8272910 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
Dual Oxidase in Airway Epithelial Repair and Remodeling
双氧化酶在气道上皮修复和重塑中的作用
- 批准号:
7808841 - 财政年份:2008
- 资助金额:
$ 38.13万 - 项目类别:
Dual Oxidase in Airway Epithelial Injury and Inflammation
双氧化酶在气道上皮损伤和炎症中的作用
- 批准号:
9397831 - 财政年份:2008
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Fellowship














{{item.name}}会员




